Deprenyl (Selegiline)
|
|
Deprenyl (Selegiline) protects and enhances mental function, mood and even libido by increasing brain levels of the focus and drive neurotransmitter- dopamine.
Deprenyl is a Parkinson drug that slows the breakdown of neurotransmitters in the brain and increases the release of dopamine. As a treatment for Alzheimer's disease, Deprenyl has showed improvement in the areas of attention and memory.
We offer Deprenyl in both tablet (Jumex) and liquid (Selepryl / Cyprenil) format. |
Deprenyl reduces the age-relateddecline of dopamine, increasing its availability to preserve youthful brainactivity
Deprenyl was originally developed as a ‘psychic energizer’, designed tointegrate some amphetamine-like brain effects with anti-depressant effects. Ithas since been shown to protect nerve cells against a wide, and growing, numberof neurotoxins, and has been shown to be a neuroprotection/neurorescue agentwhen nerve cells are exposed to damaging or stressful conditions.
Extending life-expectancy
Professor Joseph Knoll proved that Deprenyl improves the availability ofdopamine, slows its age-related decline and helps maintain healthy brain cellsby acting as a selective MAO-B inhibitor.
Professor Knoll emphasized that the nigrostriatal tract, the tiny DA-usingnerve cluster in the basal ganglia (‘old brain’), typically dies off at anaverage rate of 13% per decade starting around age 45 in humans. This fact setsthe human lifespan at about 115 years, since by that age the nigral neuronpopulation would have dropped below 10% of its original number, at which timedeath ensues even if in all other respects the organism were healthy.Therefore,human longevity is in-part governed by the rate of dopamine decline. Itssupport and enhancement means not only longer life, but lucid mentalcapabilities too. In fact, four different rat studies and one dog study haveshown Deprenyl to be an effective life-extension agent.
Based on the sum total of research, Knoll has suggested that if Deprenyl wereused from the 40s on, and only modestly lowered the nigrostriatal neuron deathrate – say, from 13% to 10% per decade – then the average human lifespan mightincrease by 15 years.
Other uses
Deprenyl has become a standard treatment for Parkinson’s disease, and thanks toits aphrodisiac effects, helps to improve sexual function and desire (much moreso for men than woman).
Although Parkinson's disease remains the only FDA approved indication forDeprenyl in the USA, with a number of ongoing clinical studies evaluating itsefficacy in Alzheimer's disease, anecdotal reports from both physicians andpatients of dramatic improvement in an impressive number of diseases have beenaccumulating.
Conditions for which Deprenyl appears to be therapeutic or ameliorativeinclude: cerebral infarction (stroke), hormone inadequacy, amyotrophiclateralizing sclerosis (lou gherig's disease), fatigue, chronic pain, gastriculcers, senile dementia, sexual dysfunction, multiple sclerosis, learningdifficulties, blepharospasm, hypertension depression and cancer.
Dosage
Parkinson and Alzheimer's disease patients are often treated with very high doses of 20mg daily (usually along with other drugs). Anti-aging doses (dependant on age and condition) are more likely to be 2.5mg to 5mg once, twice or three times a week, or, 1mg to 3mg per day, with regular breaks. Deprenyl tablets are selegiline hydrochloride, which is deprenyl bonded to an in-organic molecule.
However, liquid deprenyl citrate (LDC) is selegiline bonded to an organic molecule, one reason why the liquid deprenyl citrate is considered to be superior. This form is generally recognized as the most pure and potent form of deprenyl available. It also allows precise titration for anti-aging purposes, as each ml drop in the bottle is equivalent to 1mg deprenyl citrate. The manufacturer recommends 1mg two times a week for 30 to 35 years olds up to 10mg daily for 80 year olds plus (an age/ dosage list in English is enclosed with order). Ward Dean, M.D., recommends reducing deprenyl doses after several months to lower levels and taking occasional sabbaticals.
|
Disclaimer
This product and its statements have not been evaluated by the FDA. This product is not intended to treat, cure or prevent any disease. The above information is provided under the supplying company's terms and conditions and should not replace the advice of your personal physician.
In rare circumstances, deprenyl has been known to cause a false-positive dope test. Ristriction
This product is not available for shipment to the EU.
Caution: Japan has classified Deprenyl as a controlled substance.
|